相关实验视频

Updated: Jan 11, 2026

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

构建耐受性:利用基因组工程实现通用Treg疗法

Julian J Freen-van Heeren¹

¹Independent Scientist, The Netherlands.

Journal of leukocyte biology

|November 14, 2025

概括

科学家们设计了调节性T细胞 (Tregs) 来逃避免疫排斥,创造了"现成"的细胞疗法. 这些修改后的Tregs在未来的医疗应用中显示出诱导免疫耐受性的前景.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
基因工程是一种基因工程.

背景情况:

调节性T细胞 (Tregs) 对免疫平衡和预防自身免疫性疾病至关重要.
全球性,全基性Treg疗法的发展受到免疫排斥的阻碍.
基因组编辑为克服Treg免疫性提供了一个潜在的解决方案.

研究的目的:

为了设计基因组编辑的Tregs,避免免疫排斥,同时保持抑制功能.
评估这些改性Tregs在促进移植耐受性的有效性.
讨论通用"现成"Treg疗法的潜力和挑战.

主要方法:

使用非病毒CRISPR-Cas9基因组编辑来修改Tregs.
关键基因 (B2M,CIITA) 被删除,并插入了一个HLA-E-B2M融合.
在人性化小鼠模型中生成和测试了低免疫性Tregs.

主要成果:

经过基因组编辑的Tregs显示免疫性降低.
修改后的Tregs在人性化小鼠中持续存在并促进了移植耐受性.
工程Tregs保留了他们的免疫抑制功能.

结论:

基因工程可以创建低免疫性Tregs用于普遍的治疗用途.
这些"现成"Tregs代表了可编程免疫耐受性的重大进步.
需要进一步的研究来应对临床翻译的挑战.

关键词:

克里斯普尔是什么意思?克里斯普尔是什么意思?细胞疗法是细胞疗法.监管T细胞的监管性T细胞

更多相关视频

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

相关概念视频

What is Genetic Engineering?

What is Genetic Engineering?

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...